Rybelsus Alternatives & Comparison
Rybelsus (semaglutide) set beside Ozempic, Mounjaro, Trulicity: how each works, what its trials measured, what it costs, and who sells it.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Rybelsus Alternatives Compared
Same molecule, delivered by injection, which usually gets more out of a comparable dose
Ozempic activates GLP-1 receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, and reduce blood sugar levels.
Identical drug, two delivery routes, and the route is the whole difference. Ozempic is injected weekly; Rybelsus is a daily tablet requiring a strict fast before and after, because the SNAC absorption enhancer only works on an empty stomach. On outcomes, SUSTAIN-6 showed superiority for MACE (HR 0.74) while PIONEER 6 showed non-inferiority (HR 0.79). Retail is around $1,029 and $998. Choose on whether a daily fasting routine or a weekly needle fits your life better.
Full Ozempic vs Rybelsus comparison →Injected, and a dual GIP/GLP-1 agonist. Glycemic and weight effect generally run higher
Mounjaro's tirzepatide activates both GIP and GLP-1 receptors — making it a "dual agonist" or "twincretin." For diabetes, this dual action powerfully lowers blood sugar by increasing insulin secretion and reducing glucagon.
Two diabetes drugs, neither approved for weight management, compared mostly by people who want the weight effect anyway. SURPASS-2 reported −11.2 kg at 40 weeks for Mounjaro; PIONEER 1 reported −4.4 kg at 26 weeks for Rybelsus. Different trials and different durations. Retail sits near $1,029 and $1,069, with Lilly's card requiring commercial insurance. The dosing burden is the honest differentiator: a daily fast, or a weekly injection.
Full Mounjaro vs Rybelsus comparison →A weekly injection instead, with years of real-world safety data behind it
Dulaglutide is a long-acting GLP-1 receptor agonist engineered by fusing two modified GLP-1 peptide chains to a human IgG4 Fc fragment, which extends the half-life to about five days and allows once-weekly dosing.
Both are diabetes drugs, neither is approved for weight management, and the weight figures — −4.4 kg on Rybelsus at 26 weeks, −2 to −3 kg on Trulicity — come from diabetes programs rather than obesity trials. Rybelsus demands the fasting window that oral semaglutide absorption requires; Trulicity is one weekly injection with no food rules. Retail is near $1,029 and $987. For most people this decision is made by the formulary, not by these numbers.
Full Trulicity vs Rybelsus comparison →Compare compounded Semaglutide providers
Compounded semaglutide sits at a middle figure of $189/month across 552 price points in the register, spanning $59 to $1,400. The partners below are ordered by our partner economics.
Compare compounded Tirzepatide providers
Compounded tirzepatide sits at a middle figure of $250/month across 490 price points in the register, spanning $69 to $1,400. The partners below are ordered by our partner economics.
Compare every Rybelsus provider
Current price, verification status, product form and the states each seller ships to, all on one screen.